PubMed

Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes.

Danne T, Becker RH, Heise T, Bittner C, Frick AD, Rave K.

Diabetes Care. 2005 Sep;28(9):2100-5.PMID: 16123473 [PubMed - indexed for MEDLINE]Related articlesFree article

Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes.

Rave K, Klein O, Frick AD, Becker RH.

Diabetes Care. 2006 Aug;29(8):1812-7.PMID: 16873785 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin glulisine.

Robinson DM, Wellington K.

Drugs. 2006;66(6):861-9.PMID: 16706558 [PubMed - indexed for MEDLINE]Related articles

Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.

Ulrich H, Snyder B, Garg SK.

Vasc Health Risk Manag. 2007;3(3):245-54. Review.PMID: 17703632 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes.

Rayman G, Profozic V, Middle M.

Diabetes Res Clin Pract. 2007 May;76(2):304-12. Epub 2006 Nov 20.PMID: 17113676 [PubMed - indexed for MEDLINE]Related articles

Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.

Danne T, Lüpke K, Walte K, Von Schuetz W, Gall MA.

Diabetes Care. 2003 Nov;26(11):3087-92.PMID: 14578244 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin glulisine: a review of its use in the management of diabetes mellitus.

Garnock-Jones KP, Plosker GL.

Drugs. 2009;69(8):1035-57. doi: 10.2165/00003495-200969080-00006. Review.PMID: 19496630 [PubMed - indexed for MEDLINE]Related articles

Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine.

Garg SK, Rosenstock J, Ways K.

Endocr Pract. 2005 Jan-Feb;11(1):11-7. Erratum in: Endocr Pract. 2005 Mar-Apr;11(2):145. PMID: 16033730 [PubMed - indexed for MEDLINE]Related articles

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.PMID: 10743981 [PubMed - indexed for MEDLINE]Related articles

Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.

Hirao K, Maeda H, Urata S, Takisawa Y, Hirao S, Sasako T, Sasaki T.

Clin Ther. 2007 May;29(5):927-34.PMID: 17697911 [PubMed - indexed for MEDLINE]Related articles

Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.

Becker RH, Frick AD.

Clin Pharmacokinet. 2008;47(1):7-20. Review.PMID: 18076215 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine.

Cox SL.

Drugs Today (Barc). 2005 Jul;41(7):433-40. Review.PMID: 16193096 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.

Horvath K, Bock G, Regittnig W, Bodenlenz M, Wutte A, Plank J, Magnes C, Sinner F, Fürst-Recktenwald S, Theobald K, Pieber TR.

Diabetes Obes Metab. 2008 Jun;10(6):484-91. Epub 2007 Aug 30.PMID: 17764465 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.

Becker RH, Frick AD, Burger F, Potgieter JH, Scholtz H.

Exp Clin Endocrinol Diabetes. 2005 Sep;113(8):435-43.PMID: 16151977 [PubMed - indexed for MEDLINE]Related articles

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique.

Becker RH, Frick AD, Burger F, Scholtz H, Potgieter JH.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):292-7. Erratum in: Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):409. PMID: 15926116 [PubMed - indexed for MEDLINE]Related articles

A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.

Luzio S, Peter R, Dunseath GJ, Mustafa L, Owens DR.

Diabetes Res Clin Pract. 2008 Feb;79(2):269-75. Epub 2007 Dec 27.PMID: 18164094 [PubMed - indexed for MEDLINE]Related articles

Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes.

Garg SK, Ellis SL, Ulrich H.

Expert Opin Pharmacother. 2005 Apr;6(4):643-51. Review.PMID: 15934890 [PubMed - indexed for MEDLINE]Related articles